EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Recent Advancements and Developments of Anti‐Malarial Agents Reported in 2023

Palak K Vadodariya, Shahnaz Alom, Anu Sharma, Deepika Kathuria, Neetu Chopra, Tejas M Dhameliya iD

Archiv der Pharmazie · 2025

DOI: 10.1002/ardp.70149 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Archiv der Pharmazie, 2025. Verfasst von Palak K Vadodariya und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Sciences, Faculty of Health Sciences, Marwadi University, Rajkot, Gujarat, India. Hauptthemen laut MEDLINE: Antimalarials, Heterocyclic Compounds, Malaria, Drug Development. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 99 Literaturangaben. Gefördert von: The author received no specific funding for this work..

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Malaria, caused by Plasmodium falciparum and other species, remains a significant global health issue, transmitted by infected Anopheles mosquitoes. According to the WHO 2024 report, malaria affected 249 million individuals and resulted in 608,000 deaths between 2000 and 2022. The rise of drug resistance in both Plasmodium species and Anopheles mosquitoes has significantly complicated the malaria treatment, necessitating the development of novel therapeutic agents. This review highlights recent advancements in the design of anti‐malarial drugs, with a particular focus on heterocyclic compounds reported in 2023, in continuation of our previous works on updates on anti‐malarial agents reported since 2016. Among these, artemisinin derivatives have shown remarkable efficacy, while other heterocyclic classes—such as benzofuran, β‐lactam, coumarin, indole, morpholine, piperazine, pyrimidine, pyrrole, quinazoline, quinoline, thiazole, and triazoles—are emerging as promising alternatives. These compounds target essential parasite functions such as heme metabolism, RBC invasion, and oxidative stress pathways, with several new hybrid molecules combining multiple mechanisms of action to counter drug resistance. This review provides an overview of recent developments in these heterocyclic‐based anti‐malarial agents, summarizing their chemical structures, mechanisms of action, and therapeutic potential. By focusing on innovations reported in 2023, this study aims to orient the ongoing research in the pursuit of safer and more effective treatments for malaria.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AntimalarialsHeterocyclic CompoundsMalariaDrug DevelopmentHumansAnimalsPlasmodium falciparumMolecular StructureStructure-Activity RelationshipDrug Resistance

Stichwörter der Autor:innen

Plasmodium falciparumSARanti‐malarial agentsheterocyclesmalaria

Substanzen

AntimalarialsHeterocyclic Compounds

Autor:innen und Institutionen

  • Department of Pharmaceutical Sciences, Faculty of Health Sciences, Marwadi University, Rajkot, Gujarat, India.
  • Girijananda Chowdhury Institute of Pharmaceutical Science, Girijananda Chowdhury University-Tezpur campus, Guwahati, Assam, India.
  • Department of Pharmaceutical Sciences, Faculty of Science and Engineering, Dibrugarh University, Dibrugarh, Assam, India.
  • Department of Chemistry, University of Massachusetts Boston, Boston, Massachusetts, USA.
  • University Centre for Research and Development, Chandigarh University, Mohali, Punjab, India.
  • Chandigarh College of Pharmacy, Chandigarh Group of Colleges, Landran, Punjab, India.

ORCID-Profile: Tejas M Dhameliya

Förderung

  • The author received no specific funding for this work.

Zitieren

APA

Vadodariya, P. K., Alom, S., Sharma, A., Kathuria, D., Chopra, N., & Dhameliya, T. M. (2025). Recent Advancements and Developments of Anti‐Malarial Agents Reported in 2023. Archiv der Pharmazie. https://doi.org/10.1002/ardp.70149

Vancouver

Vadodariya PK, Alom S, Sharma A, Kathuria D, Chopra N, Dhameliya TM. Recent Advancements and Developments of Anti‐Malarial Agents Reported in 2023. Archiv der Pharmazie. 2025. doi:10.1002/ardp.70149

BibTeX
@article{Vadodariya2025,
  author = {Vadodariya, Palak K and Alom, Shahnaz and Sharma, Anu and Kathuria, Deepika and Chopra, Neetu and Dhameliya, Tejas M},
  title = {Recent Advancements and Developments of Anti‐Malarial Agents Reported in 2023},
  journal = {Archiv der Pharmazie},
  year = {2025},
  doi = {10.1002/ardp.70149}
}
Kostenlos starten →